GCM
KURA icon

Ghisallo Capital Management’s Kura Oncology KURA Stock Holding History

Ghisallo Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-45,000
Closed -$476K – 146
2023
Q2 		$476K Buy
+45,000
New +$532K 0.06% 107

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ghisallo Capital Management's KURA Position: Q3 2023 in Review

Ghisallo Capital Management sold out of Kura Oncology (KURA) in Q3 2023, closing a stake of 45,000 shares — an estimated $476K sold.

Ghisallo Capital Management first reported a position in KURA in Q2 2023 and held it in 1 quarter. The position peaked at $476K in Q2 2023. 133 funds tracked by Wall St. Rank hold KURA as of Q3 2023.

  • Ghisallo Capital Management reported no remaining Kura Oncology position as of Q3 2023 after selling out during the quarter.
  • Ghisallo Capital Management sold 45,000 Kura Oncology shares in Q3 2023, an estimated $476K.
  • Ghisallo Capital Management first reported a position in Kura Oncology in Q2 2023 and held it in 1 quarter.
  • Ghisallo Capital Management's Kura Oncology position peaked at $476K in Q2 2023.
  • 133 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2023.

Based on Ghisallo Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.